ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 156625 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 156625; 2) Community: the network communities that were significantly associated with the response to NSC 156625; 3) Molecule: the relationships between components within communities and NSC 156625; 4) MDR: the compounds that were significantly associated with the NSC 156625.

NSC Compound Enrichment Correlation
NSC 710326 Null 0.0352028253287042 -0.25617135
NSC 716503 Null 0.0352028253287042 -0.33699289
NSC 718781 Erlotinib hydrochloride 0.0352028253287042 -0.3422248
NSC 726217 Combretastatin A4-analogue 0.0352028253287042 -0.19410524
NSC 734141 6-(3-Aminopropyl)-5,6-dihydro-8,9-dimethoxy-3-nitro-5,11-dio xo-11H-indeno[1,2-c]isoquinoline Hydrochloride 0.0352028253287042 -0.11894719
NSC 748147 5-methyl-2-{[(2)-3-phenylprop-2-enoyl]amino}benzamide 0.0352028253287042 0.12546542
NSC 751042 Null 0.0352028253287042 -0.020725511
NSC 87864 N-Salicylidene-N-salicyloylhydrazine 0.0352028253287042 -0.09343801
NSC 92207 Null 0.0352028253287042 -0.22920156
NSC 753203 N-(2-(4-(6-(4-fluorophenyl)imidazo[2,1-b]thiazol-5-yl)pyrimidin-2-ylamino)ethyl)-4-methoxybenzamide 0.0361455178924426 -0.026925657
Total:71  Current:47    [First] [Prev] [Next] [Last]